Acute effects of short‐chain alkylglycerols on blood‐brain barrier properties of cultured brain endothelial cells

No abstract is available for this paper.

• Publication year

  2013

• Venue

  British Journal of Pharmacology

• Publication date

  2013-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/bph.12218PMID 23617601PMCID PMC3724112
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of P‐glycoprotein enhances transport of imipramine across the blood–brain barrier: microdialysis studies in conscious freely moving rats

  2012cited by this paper
• Tools for modelling blood-brain barrier penetrability

  2011cited by this paper
• Drug transport and the blood-brain barrier

  2011cited by this paper
• Elucidating the principles of the molecular organization of heteropolymeric tight junction strands

  2011cited by this paper
• COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats.

  2010cited by this paper
• Prostanoid EP1 receptor antagonist reduces blood-brain barrier leakage after cerebral ischemia.

  2010cited by this paper
• Vascular Endothelial-Cadherin Stabilizes at Cell–Cell Junctions by Anchoring to Circumferential Actin Bundles through α- and β-Catenins in Cyclic AMP-Epac-Rap1 Signal-activated Endothelial Cells

  2010cited by this paper
• Participation of the second extracellular loop of claudin-5 in paracellular tightening against ions, small and large molecules

  2010cited by this paper
• Monitoring Proteins Using In Vivo Near-Infrared Time-Domain Optical Imaging after 2-O-Hexyldiglycerol-Mediated Transfer to the Brain

  2010cited by this paper
• Structure and Function of Extracellular Claudin Domains

  2009cited by this paper
• Physiology and function of the tight junction.

  2009cited by this paper
• Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery.

  2009cited by this paper
• Functions of lipid raft membrane microdomains at the blood–brain barrier

  2009cited by this paper
• The role of adherens junctions and VE-cadherin in the control of vascular permeability

  2008cited by this paper
• Structure and function of claudins.

  2008cited by this paper
• Identification and Design of Peptides as a New Drug Delivery System for the Brain

  2008cited by this paper
• Adherens and tight junctions: structure, function and connections to the actin cytoskeleton.

  2008cited by this paper
• Formation of tight junction: determinants of homophilic interaction between classic claudins

  2008cited by this paper
• Methotrexate loaded polyether-copolyester dendrimers for the treatment of gliomas: enhanced efficacy and intratumoral transport capability.

  2008cited by this paper
• Endothelial adherens junctions control tight junctions by VE-cadherin-mediated upregulation of claudin-5

  2008cited by this paper
• Pentosan polysulfate protects brain endothelial cells against bacterial lipopolysaccharide-induced damages.

  2007cited by this paper
• On the self-association potential of transmembrane tight junction proteins

  2006cited by this paper
• Astrocyte–endothelial interactions at the blood–brain barrier

  2006cited by this paper
• Recent advances in the treatment of malignant astrocytoma.

  2006cited by this paper
• Critical role of actin in modulating BBB permeability.

  2005cited by this paper
• Permeability Studies on In Vitro Blood–Brain Barrier Models: Physiology, Pathology, and Pharmacology

  2005cited by this paper
• Hyperosmotic mannitol induces Src kinase‐dependent phosphorylation of β‐catenin in cerebral endothelial cells

  2005influential reference
• Blood–brain barrier opening with alkylglycerols: Biodistribution of 1-O-pentylglycerol after intravenous and intracarotid administration in rats

  2005cited by this paper
• Puromycin‐based purification of rat brain capillary endothelial cell cultures. Effect on the expression of blood–brain barrier‐specific properties

  2005cited by this paper
• Differential roles for actin polymerization and a myosin II motor in assembly of the epithelial apical junctional complex.

  2005cited by this paper
• Modulation of the blood-brain barrier in oncology: therapeutic opportunities for the treatment of brain tumours?

  2004cited by this paper
• RhoA, Rac1, and Cdc42 exert distinct effects on epithelial barrier via selective structural and biochemical modulation of junctional proteins and F-actin.

  2004cited by this paper
• Blood-brain barrier efflux transport.

  2003cited by this paper
• Intracarotid administration of short‐chain alkylglycerols for increased delivery of methotrexate to the rat brain

  2003cited by this paper
• Alkylglycerol opening of the blood–brain barrier to small and large fluorescence markers in normal and C6 glioma‐bearing rats and isolated rat brain capillaries

  2003cited by this paper
• Drug and gene targeting to the brain with molecular trojan horses

  2002cited by this paper
• Transport of paclitaxel (Taxol) across the blood-brain barrier in vitro and in vivo.

  2002cited by this paper
• Increased delivery of erucylphosphocholine to C6 gliomas by chemical opening of the blood-brain barrier using intracarotid pentylglycerol in rats

  2002cited by this paper
• Osmotic Opening of the Blood–Brain Barrier: Principles, Mechanism, and Therapeutic Applications

  2000influential reference
• Safety and efficacy of a multicenter study using intraarterial chemotherapy in conjunction with osmotic opening of the blood‐brain barrier for the treatment of patients with malignant brain tumors

  2000cited by this paper
• Transient and controllable opening of the blood-brain barrier to cytostatic and antibiotic agents by alkylglycerols in rats

  2000cited by this paper
• In vivo assessment of the window of barrier opening after osmotic blood-brain barrier disruption in humans.

  2000cited by this paper
• The cell biology of the blood-brain barrier.

  1999cited by this paper
• Regulation of the movement of solutes across tight junctions.

  1998cited by this paper
• A Single Gene Product, Claudin-1 or -2, Reconstitutes Tight Junction Strands and Recruits Occludin in Fibroblasts

  1998cited by this paper
• Paracellular diffusion in Caco-2 cell monolayers: effect of perturbation on the transport of hydrophilic compounds that vary in charge and size.

  1997cited by this paper
• Hypoxia Dramatically Increases the Nonspecific Transport of Blood‐Borne Proteins to the Brain

  1997cited by this paper
• Penetration of small molecular weight substances through cultured bovine brain capillary endothelial cell monolayers: the early effects of cyclic adenosine 3',5'‐monophosphate

  1995cited by this paper
• Modulation of tight junction structure in blood-brain barrier endothelial cells. Effects of tissue culture, second messengers and cocultured astrocytes.

  1994cited by this paper
• Selective Paracellular Permeability in Two Models of Intestinal Absorption: Cultured Monolayers of Human Intestinal Epithelial Cells and Rat Intestinal Segments

  1993cited by this paper
• Hyperosmolar Opening of the Blood-Brain Barrier in the Energy-Depleted Rat Brain. Part 1. Permeability Studies

  1988cited by this paper
• [Blood-brain barrier and the penetration of cytostatic drugs].

  1985cited by this paper
• Osmotic blood-brain barrier modification: monoclonal antibody, albumin, and methotrexate delivery to cerebrospinal fluid and brain.

  1985influential reference
• Blut-Hirnschranke und Penetration von Zytostatika

  1985cited by this paper
• FINE STRUCTURAL LOCALIZATION OF A BLOOD-BRAIN BARRIER TO EXOGENOUS PEROXIDASE

  1967cited by this paper

• Bacterial infection hypothesis-based therapies for Alzheimer's disease

  2025cites this paper
• Polypharmacology approaches for brain disorders aimed to enhance brain permeability and circadian clock targeting.

  2025cites this paper
• A guide for blood–brain barrier models

  2024cites this paper
• Transnasal targeted delivery of therapeutics in central nervous system diseases: a narrative review

  2023cites this paper
• Nose-to-Brain (N2B) Delivery: An Alternative Route for the Delivery of Biologics in the Management and Treatment of Central Nervous System Disorders

  2023cites this paper
• Regulation of pathological blood-brain barrier for intracranial enhanced drug delivery and anti-glioblastoma therapeutics

  2022cites this paper
• Strategies to overcome/penetrate the BBB for systemic nanoparticle delivery to the brain/brain tumor.

  2022cites this paper
• Blood–brain barrier dysfunction in l-ornithine induced acute pancreatitis in rats and the direct effect of l-ornithine on cultured brain endothelial cells

  2022cites this paper
• Mycobacterium bovis Bacillus Calmette–Guérin–Infected Dendritic Cells Induce TNF-α–Dependent Cell Cluster Formation That Promotes Bacterial Dissemination through an In Vitro Model of the Blood–Brain Barrier

  2021cites this paper
• Modulating the Blood–Brain Barrier: A Comprehensive Review

  2021cites this paper
• Overcoming the blood-brain barrier in neurodegenerative disorders and brain tumours.

  2020cites this paper
• Pharmacokinetics of Drug Delivery Past the Blood–Brain Barrier

  2019cites this paper
• Tight junction proteins at the blood–brain barrier: far more than claudin-5

  2019cites this paper
• Physically open BBB

  2019cites this paper
• A comprehensive review in improving delivery of small-molecule chemotherapeutic agents overcoming the blood-brain/brain tumor barriers for glioblastoma treatment

  2019cites this paper
• Approaches in Barriers, Modifications, Route of Administrations, and Formulations of Therapeutic Agents for Brain Delivery

  2019cites this paper
• Bioactive Lipids

  2019cites this paper
• Reversible opening of the blood-brain barrier by claudin-5-binding variants of Clostridium perfringens enterotoxin's claudin-binding domain.

  2018cites this paper
• Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood‐brain barrier

  2018cites this paper
• Biochemical characterization of ratfish (Chimaera monstrosa) liver oil; cytotoxic and antineoplastic evaluation in cancer cell lines

  2018cites this paper
• Blood–Brain Barrier and Edema in Brain Tumors

  2017cites this paper
• Crossing the Blood–Brain Barrier: Recent Advances in Drug Delivery to the Brain

  2017cites this paper
• Self‐assembled amphiphilic core‐shell nanocarriers in line with the modern strategies for brain delivery

  2017cites this paper
• Freeze fracture: new avenues for the ultrastructural analysis of cells in vitro

  2017cites this paper
• Nanoparticles of alkylglyceryl dextran and poly(ethyl cyanoacrylate) for applications in drug delivery: Preparation and characterization

  2017cites this paper
• Tight junction modulation of the blood brain barrier: CNS delivery of small molecules

  2016cites this paper
• Modulation of tight junctions by peptides to increase drug penetration across biological barriers

  2016cites this paper
• Carbohydrate Nanoparticles for Brain Delivery.

  2016cites this paper
• Pharmaceutical Targeting of the Brain.

  2016cites this paper
• Selective cytotoxic effect of 1-O-undecylglycerol in human melanoma cells

  2016cites this paper
• High-Throughput Screening for Identification of Blood-Brain Barrier Integrity Enhancers: A Drug Repurposing Opportunity to Rectify Vascular Amyloid Toxicity

  2016cites this paper
• A versatile lab-on-a-chip tool for modeling biological barriers

  2016cites this paper
• Strategies that Target Tight Junctions for Enhanced Drug Delivery.

  2016cites this paper
• NEW AGENTS TO OPEN THE BLOOD-BRAIN BARRIER : THE EFFECTS OF TESMILIFENE AND SHORT-CHAIN ALKYLGLYCEROLS ON BRAIN ENDOTHELIAL CELLS

  2015cites this paper
• Hydrophilic bile acids protect human blood-brain barrier endothelial cells from disruption by unconjugated bilirubin: an in vitro study

  2015cites this paper
• Tesmilifene modifies brain endothelial functions and opens the blood–brain/blood–glioma barrier

  2015cites this paper
• Transfer of opiorphin through a blood-brain barrier culture model.

  2015cites this paper
• Nanoparticles of alkylglyceryl-dextran-graft-poly(lactic acid) for drug delivery to the brain: Preparation and in vitro investigation.

  2015cites this paper
• Blood-brain barrier co-culture models to study nanoparticle penetration: focus on co-culture systems

  2015cites this paper
• Cyclodextrins, blood-brain barrier, and treatment of neurological diseases.

  2014cites this paper
• Delivery of therapeutic peptides and proteins to the CNS.

  2014cites this paper